DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Kendler D, Chines A, Clark P. et al.
Bone mineral density after transitioning from denosumab to alendronate.
J Clin Endocrinol Metab 2020;
105: e255-e264
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.